Early dexamethasone treatment after implantation of a sciatic-nerve cuff decreases the concentration of substance P in the lumbar spinal cord of rats with neuropathic pain

Canadian Journal of Veterinary Research

Volumn 71, Issue 2, 2007, Pages 90-97

  Beaudry, Francis ^a   Girard, Christiane ^a   Vachon, Pascal ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CHOLECYSTOKININ; DEXAMETHASONE; NEUROTENSIN; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

AFFERENT NERVE GROUP 1; ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HISTOPATHOLOGY; INFLAMMATION; LIQUID CHROMATOGRAPHY; LUMBAR SPINE; MALE; MICROSCOPY; NERVE COMPRESSION; NERVE FIBER C; NERVE GRAFT; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PATHOPHYSIOLOGY; POSTOPERATIVE CARE; PROTEIN ANALYSIS; RAT; SCIATIC NERVE; SPRAGUE DAWLEY RAT; TANDEM MASS SPECTROMETRY; THERAPY EFFECT; TISSUE FIXATION; TISSUE SECTION; TOUCH;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CALCITONIN; CHOLECYSTOKININ; CHROMATOGRAPHY, LIQUID; CONSTRICTION; DEXAMETHASONE; DISEASE MODELS, ANIMAL; MALE; MASS SPECTROMETRY; NERVE FIBERS; NEUROTENSIN; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE; SCIATIC NEUROPATHY; SPINAL CORD; SUBSTANCE P; TIME FACTORS; TREATMENT OUTCOME;

ANIMALIA; RATTUS;

EID: 34248339277     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Pitcher GM, Ritchie J, Henry JL. Nerve constriction in the rat: model of neuropathic, surgical and central pain. Pain 1999;83: 37-46.
2. Bennett GJ, Xie YK. A peripheral mononeuropathy in rat produces disorders of pain sensation like those seen in man. Pain 1988;33:87-107.
3. Decostered I, Wolf CJ. Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 2000;87:149-158.
4. Hofmann HA, De Vry J, Siegling A, Spreyer P, Denzer D. Pharmacological sensitivity and gene expression analysis of the tibial nerve injury model of neuropathic pain. Eur J Pharmacol 2003;470:17-25.
5. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992;50:355-363.
6. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced by partial sciatic nerve injury. Pain 1990;43:205-218.
7. Walczak JS, Pichette V, Leblond F, Desbiens K, Beaulieu P. Behavioral, pharmacological and molecular characterization of the saphenous nerve partial ligation: a model neuropathic pain. Neuroscience 2005;132:1093-1102.
8. Johanson A, Bennett GJ. Effect of local methylprednisolone in a nerve injury model. Reg Anesth 1997;22:59-65.
9. Takeda K, Sawamura S, Sekiyama H, Tamai H, Hanaoka K. Effect of methylprednisolone on neuropathic pain and glial activation in rats. Anesthesiology 2004;100:1249-1257.
10. Kingery WS, Castellote JM. Methylprednisolone prevents the development of autotomy and neuropathic edema in rats, but has no effect on nociceptive thresholds. Pain 1999;80:555-566.
11. Fürst J. Transmitters involved in antinociception in the spinal cord. Brain Res Bull 1999;48:129-141.
12. Yaksh TL, Michener SR, Bailey JE, et al. Survey of distribution of substance P, vasoactive intestinal peptide, cholecystokinin, neurotensin, met-enkephalin, bombesin and PHI in the spinal cord of cat, dog, sloth and monkey. Peptides 1988;9:357-372.
13. Zhang RX, Mi ZP, Qiao JT. Changes of spinal substance P, calcitonin gene-related peptide, somatostatin, met-enkephalin and neurotensin in rats in response to formalin-induced pain. Regul Pept 1994;51:25-32.
14. Vachon P, Masse R, Gibbs B. Substance P and neurotensin are upregulated in the spinal cord of animals with neuropathic pain. Can J Vet Res 2004;68:86-92.
15. Clatworthy AL, Illich PA, Castro GA, Walters ET. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behaviour in a rat model of neuropathic pain. Neurosci Lett 1995;184:5-8.
16. Cunha FQ, Lorenzetti BB, Poole S, Ferreira SH. Interleukin-8 as a mediator of sympathetic pain. Br J Pharmacol 1991;104:765-767.
17. Sommer C, Galbraith JA, Heckman HM, Meyers RR. Pathology of experimental compression neuropathy producing hyperesthesia. J Neuropathol Exp Neurol 1993;52:223-233.
18. Campbell JN, Raja SN, Cohen RH, Manning DC, Khan AA, Meyer RA. Peripheral neural mechanisms of nociception. In: Wall PD, Melzack R, eds. Textbook of Pain. Churchill Livingston, New York, 1989:22-45.
19. Dickenson AH, Susuki R, Matthews EA, et al. Balancing excitation and inhibitions in spinal circuits. In: Villanueva L, Dickenson AH, Ollat OH, eds. The Pain System in Normal and Pathological States: a Primer for Clinicians. Progress in Pain and Research, vol 31. Seattle, Washington: IASP Press, 2004:79-105.
20. Carlton SM, Dougherty PM, Pover CM, Coggeshall RE. Neuroma formation and number of axons in a rat model of experimental peripheral neuropathy. Neursci Lett 1991;131:88-92.
21. Coggeshall RE, Dougherty PM, Pover CM, Carlton SM. Is large myelinated fibre loss associated with hyperalgesia in a model of experimental peripheral neuropathy in rats? Pain 1993;52: 233-242.
22. Wang S, Lim G, Zeng Q, et al. Expression of central glucocorticoid receptors after peripheral nerve injury contributes to neuropathic pain behaviours in rats. J Neurosci 2004;24:8595-8605.
23. Wang S, Lim G, Zeng Q, Sung B, Yang L, Mao J. Central glucocorticoid receptors modulate the expression and function of spinal NMDA receptors after peripheral nerve injury. J Neurosci 2005;25:488-495.
24. Lema PP, Girard C, Vachon P. Dexamethasone for the treatment of intracerebral hemorrhage using a collagenase-induced cerebral hematoma rat model. J Vet Pharmacol Ther 2004;27:321-328.
25. Bridges D, Thompson SWN, Rice ASC. Mechanisms of neuropathic pain. Br J Anaesth 2001;87:12-26.
26. Woolf CJ, Shortland P, Coggeshall RE. Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 1992;335:75-78.
27. Hunt SP. Molecular approaches to the study of pain. In: Villanueva L, Dickenson AH, Ollat OH, eds. The Pain System in Normal and Pathological States: a Primer for Clinicians. Progress in Pain and Research, vol 31. Seattle, Washington: IASP Press, 2004:57-77.
28. Barber RP, Vaughn JE, Slemmon JR, Salvaterra PM, Roberts E, Leeman SE. The origin, distribution and synaptic relationships of substance P in rat spinal cord. J Comp Neurol 1979;184:331-352.
29. Hokfelt T, Elde R, Johansson O, Luft R, Nilsson G, Arimura A. Immunohistochemical evidence for separate populations of somatostatin-containing and substance P-containing primary afferent neurons. Neuroscience 1976;1:131-136.
30. Henry JL. Effects of substance P on functionally identified units in cat spinal cord. Exp Neurol 1976;114:439-452.
31. Yaksh TL, Jessell TM, Gamse R, Mudge AW, Leeman SE. Intrathecal morphine inhibits substance P release from mammalian spinal cord in vivo. Nature 1980;286:155-156.
32. Yamamoto T, Yaksh TL. Stereospecific effects of a nonpeptidic NK1 selective antagonist, CP-96,345: antinociception in the absence of motor dysfunction. Life Sci 1991;49:1955-1963.